Cambridge Investment Research Advisors’s AllianzIM Buffer15 Uncapped Allocation ETF SPBU Stock Holding History

Cambridge Investment Research Advisors’s Portfolio SPBU Stock Details SPBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.39M	Buy	46,055 +16,841	+58%	+$497K	﹤0.01%	1990
2026 Q1	$794K	Sell	29,214 -5,782	-17%	-$162K	﹤0.01%	2370
2025 Q4	$985K	Buy	34,996 +11,346	+48%	+$318K	﹤0.01%	2107
2025 Q3	$655K	Buy	23,650 +2,552	+12%	+$68.3K	﹤0.01%	2426
2025 Q2	$549K	Buy	+21,098	New	+$520K	﹤0.01%	2452

Other funds holding SPBU

Savant Capital Rockford, Illinois $34.1B AUM 22.4% 1-Year Est. Return

TCG

Transcendent Capital Group Edmond, Oklahoma $257M AUM 25.68% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Optima Capital Beaverton, Oregon $253M AUM 21.52% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

CWAF

Core Wealth Advisors (Florida) Lakeland, Florida $497M AUM 20.85% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Cambridge Investment Research Advisors's SPBU Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its AllianzIM Buffer15 Uncapped Allocation ETF (SPBU) stake by 58% in Q2 2026, buying an estimated $497K and bringing the position to 46,055 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1990.

Cambridge Investment Research Advisors first reported a position in SPBU in Q2 2025 and has held it in 5 quarters since. 45 funds tracked by Wall St. Rank hold SPBU as of Q2 2026.

Cambridge Investment Research Advisors held 46,055 shares of AllianzIM Buffer15 Uncapped Allocation ETF worth $1.39M as of Q2 2026.
Cambridge Investment Research Advisors bought 16,841 AllianzIM Buffer15 Uncapped Allocation ETF shares in Q2 2026, an estimated $497K.
AllianzIM Buffer15 Uncapped Allocation ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1990 holding.
Cambridge Investment Research Advisors first reported a position in AllianzIM Buffer15 Uncapped Allocation ETF in Q2 2025 and has held it in 5 quarters since.
45 funds tracked by Wall St. Rank held AllianzIM Buffer15 Uncapped Allocation ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.